Synapse - Jennifer Sauter

Search Within

Jennifer Lynn Sauter

Results (83)

Utility of methylthioadenosine physphorylase (MTAP), 5-hydroxymethylcystosine (5-hmc) and BAP1 immunocytochemistry (ICC) in cytology specimens for the diagnosis of malignant mesothelioma (MM)

Meeting Abstract

Raza, R.; Travis, W.; Adusumilli, P.; Asher, M.; Buonocore, D.; Chang, J.; Frosina, D.; Jungbluth, A.; Linkov, I.; Rekhtman, N.; more...
Laboratory Investigation (2020)

Fulltext@MSK | Save

Novel biological subsets of small cell lung carcinoma defined by ASCL1 and NeuroD1: Immunohistochemical and histopathological characterization

Meeting Abstract

Baine, M.; Lai, W. C.; Egger, J.; Rizvi, H.; Beras, A.; Travis, W.; Sauter, J.; Chang, J.; Buonocore, D.; Jungbluth, A.; more...
Laboratory Investigation (2020)

Fulltext@MSK | Save

The genomic landscape of SMARCA4 alterations and association with patient outcomes in lung cancer

Meeting Abstract

Schoenfeld, A. J.; Montecalvo, J.; Namakydoust, A.; Lavery, J.; Bandlamudi, C.; Rizvi, H.; Paul, S.; Arcila, M.; Chang, J.; Sauter, J.; more...
Journal of Thoracic Oncology (2020)

Fulltext@MSK | Save

V-domain Ig-containing suppressor of T-cell activation (VISTA), a potentially targetable immune checkpoint molecule, is highly expressed in epithelioid malignant pleural mesothelioma

Journal Article

Muller, S.; Lai, W. V.; Adusumilli, P. S.; Desmeules, P.; Frosina, D.; Jungbluth, A.; Ni, A.; Eguchi, T.; Travis, W. D.; Ladanyi, M.; more...
Modern Pathology (2020)

Fulltext@MSK | Save

SMARCA4-deficient thoracic sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas

Journal Article

Rekhtman, N.; Montecalvo, J.; Chang, J. C.; Alex, D.; Ptashkin, R. N.; Ai, N.; Sauter, J. L.; Kezlarian, B.; Jungbluth, A.; Desmeules, P.; more...
Journal of Thoracic Oncology (2020)

Fulltext@MSK | Save

Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50%

Journal Article

Gainor, J. F.; Rizvi, H.; Jimenez Aguilar, E.; Skoulidis, F.; Yeap, B. Y.; Naidoo, J.; Khosrowjerdi, S.; Mooradian, M.; Lydon, C.; Illei, P.; more...
Annals of Oncology (2020)

Fulltext@MSK | Save

Comprehensive next-generation sequencing unambiguously distinguishes separate primary lung carcinomas from intrapulmonary metastases: Comparison with standard histopathologic approach

Journal Article

Chang, J. C.; Alex, D.; Bott, M.; Tan, K. S.; Seshan, V.; Golden, A.; Sauter, J. L.; Buonocore, D. J.; Vanderbilt, C. M.; Gupta, S.; more...
Clinical Cancer Research (2019)

Fulltext@MSK | Save

Multifactorial model to predict response to PD-(L)1 blockade in patients with high PD-L1 metastatic non-small cell lung cancer

Meeting Abstract

Arbour, K.; Oprescu, M.; Hakim, J.; Rizvi, H.; Leiserson, M.; Ginsburg, M.; Plodkowski, A.; Sauter, J.; Preeshagul, I.; Gillett, S.; more...
Journal of Thoracic Oncology (2019)

Fulltext@MSK | Save

Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression

Journal Article

Aguilar, E. J.; Ricciuti, B.; Gainor, J. F.; Kehl, K. L.; Kravets, S.; Dahlberg, S.; Nishino, M.; Sholl, L. M.; Adeni, A.; Subegdjo, S.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

Association of BAP1 alterations with malignant pleural mesothelioma treated with trimodality therapy

Meeting Abstract

Zauderer, M. G.; Rizvi, H.; DuBoff, M. A.; Adusumilli, P. S.; Rusch, V. W.; Sauter, J. L.; Ladanyi, M.; Rimner, A.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save